Biotech

All Articles

Exelixis drops ADC after determining it is actually no match for Tivdak

.Exelixis is actually surrendering on its tissue element (TF)- targeting antibody-drug conjugate aft...

Relay dislikes SHP2 prevention after Genentech leaves

.3 full weeks after Roche's Genentech device ignored an SHP2 prevention pact, Relay Therapeutics has...

Stoke's Dravet disorder med released of partial scientific hold

.Stoke Therapeutics' Dravet disorder medication has been devoid of a partial hold, clearing the meth...

Fierce Biotech's Gabrielle Masson presents Brutal 15 at NYSE

.Ferocious Biotech Colleague Publisher Gabrielle Masson presented the 2024 course of Brutal 15 victo...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its once-monthly dual GLP-1/ GIP receptor agonist, finishing (PDF) advancemen...

Daiichi pays Merck $170M to create bronchi cancer cells T-cell engager contract

.Merck &amp Co. has actually quickly recouped a number of the expenses of its own Javelin Therapeuti...

BioMarin stops preclinical genetics therapy for heart disease

.After BioMarin carried out a springtime well-maintained of its pipeline in April, the company has d...

Eisai plants molecular glue SEED along with $1.5 B biobucks handle

.Significant Pharmas remain stuck to the suggestion of molecular adhesive degraders. The latest comp...

Life scientific research credit score firm reveals along with $600M

.A new global life science credit scores company, nicknamed Symbiotic Capital, has raised much more ...

BMS trenches TIGIT, leaving $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing one more large wager coming from the Caforio era, canceling ...